FOR IMMEDIATE RELEASE: Monday, November 17, 2014
CONTACT: Catherine McCarthy (202) 232-2211; email@example.com
DC Department of Health Releases New Study:
HIV Prevention Campaigns Effective; Contribute to Reduction in HIV Rates
(Washington, D.C.) – Today the District of Columbia Department of Health (DOH) released a new report, “DC Takes On HIV: Public Awareness, Resident Engagement and a Call to Action,” which details the results of an extensive survey of residents’ awareness, knowledge, and behavior associated with the city’s five-year social marketing campaign for HIV prevention.
THE WORLD'S MOST EFFECTIVE HIV PREVENTION DRUG HASN'T LIVED UP TO ITS POTENTIAL - Washington Post - November 3, 2014
By Heather Boerner
Nick Gourdine headed to his doctor’s office from his apartment in Southeast Washington one day in 2011 with HIV on his mind. He’d hooked up with a friend, someone he thought he knew but who turned out to have withheld a crucial bit of information: He was HIV-positive. Now Gourdine worried that he was, too.
His HIV test came back negative. To keep it that way, Gourdine, a 35-year-old youth program manager, became an early user of a combination drug to ward off HIV infection that has generated excitement and discussion among scientists and activists.
The drug, Truvada, and the prevention approach, called pre-exposure prophylaxis, or PrEP, are increasingly at the center of efforts to keep such people as Nick negative. While the Food and Drug Administration approved Truvada for PrEP in 2012, only a few thousand people currently take it, according to the drug’s maker, Gilead Sciences. The Centers for Disease Control and Prevention estimates that at least 500,000 could benefit from it.
About 50,000 Americans are diagnosed with HIV every year, according to CDC statistics from 2011. That year, the number included 959 people in the District.